The most cited GH secretagogue research combination: GHRH (CJC-1295) plus GHSR (ipamorelin). Two independent stimulation axes in one reconstitution.
CJC-1295 and ipamorelin are commonly blended because they engage complementary points on the GH secretagogue pathway. CJC-1295 activates the GHRH axis; ipamorelin activates the GHSR (ghrelin) axis. The two signals synergise on GH release without redundancy.
Why the combination is documented together
- GHRH-axis stimulation (CJC-1295) — pituitary somatotroph activation.
- GHSR-axis stimulation (ipamorelin) — additional release without prolactin/cortisol confound.
- Independent mechanisms allow additive PK modelling in published research.
Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.
